In vivo drug discovery in the zebrafish

Nature Reviews Drug Discovery

Volumn 4, Issue 1, 2005, Pages 35-44

  Zon, Leonard I ^a   Peterson, Randall T ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDIABETIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BENZODIAZEPINE; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; COMPLEMENTARY DNA; DIGOXIN; DRUG; EZETIMIBE; GABAPENTIN; HYDROCHLOROTHIAZIDE; ISONIAZID; METFORMIN; OPIATE; SILDENAFIL; WARFARIN;

CHEMICAL MUTAGENESIS; DRUG RESEARCH; DRUG SCREENING; DRUG TARGETING; EXPERIMENTAL MODEL; FERTILITY; GENE EXPRESSION PROFILING; GENE INSERTION; GENE MAPPING; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; IN VITRO STUDY; IN VIVO STUDY; MAMMAL; MORPHOLOGY; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; TOXICOLOGY; TRANSGENICS; ZEBRA FISH;

ANIMALS; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; MODELS, ANIMAL; TOXICITY TESTS; ZEBRAFISH;

EID: 12144273121     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1606     Document Type: Review

References (82)

1. Eisen, J. S. Zebrafish make a big splash. Cell 87 969-977 (1996).
2. Driever, W. et al. A genetic screen for mutations affecting embryogenesis in zebrafish. Development 123, 37-46 (1996).
3. Haffter, P. et al. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123, 1-36 (1996).
4. Stickney H. L. et al. Rapid mapping of zebrafish mutations with SNPs and oligonucleotide microarrays. Genome Res. 12, 1929-1934 (2002).
5. Ton, C., Stamatiou, D., Dzau, V. J. & Liew, C. C. Construction of a zebrafish cDNA microarray: gene expression profiling of the zebrafish during development. Biochem. Biophys. Res. Commun. 296, 1134-1142 (2002).
6. Nasevicius, A. & Ekker, S. C. Effective targeted gene 'knockdown' in zebrafish. Nature Genet. 26, 216-220 (2000).
7. Heasman, J. Morpholino oligos: making sense of antisense? Dev. Biol. 243, 209-214 (2002).
8. Meng, A., Jessen, J. R. & Lin, S. Transgenesis. Methods Cell Biol. 60, 133-148 (1999).
9. Davidson, A. E. et al. Efficient gene delivery and gene expression in zebrafish using the Sleeping Beauty transposon. Dev. Biol. 263, 191-202 (2003).
10. Kurita, K., Burgess, S. M. & Sakai, N. Transgenic zebrafish produced by retroviral infection of in vitro-cultured sperm. Proc. Natl Acad. Sci. USA 101, 1263-1267 (2004).
11. Wienholds, E., Schulte-Merker, S., Walderich, B. & Plasterk, R. H. Target-selected inactivation of the zebrafish rag1 gene. Science 297, 99-102 (2002).
12. Lee, K. Y., Huang, H., Ju, B., Yang, Z. & Lin, S. Cloned zebrafish by nuclear transfer from long-term-cultured cells. Nature Biotechnol. 20, 795-799 (2002).
13. Bhatt, D. H., Otto, S. J., Depoister, B. & Fetcho, J. R. Cyclic AMP-induced repair of zebrafish spinal circuits. Science 305, 254-258 (2004).
14. Farber, S. A. et al. Genetic analysis of digestive physiology using fluorescent phospholipid reporters. Science 292 1385-1388 (2001).
15. Lindsay, M. A. Target discovery. Nature Rev. Drug Discov. 2, 831-838 (2003).
16. Bleicher, K. H., Bohm, H. J., Muller, K. & Alanine, A. I. Hit and lead generation: beyond high-throughput screening. Nature Rev. Drug Discov. 2, 369-378 (2003).
17. Armer, R. E. & Morris, I. D. Trends in early drug safety. Drug News Perspect. 17, 143-148 (2004).
18. Shin, J. T. & Fishman, M. C. From zebrafish to human: modular medical models. Annu. Rev. Genomics Hum. Genet. 3, 311-340 (2002).
19. Rubinstein, A. L. Zebrafish: from disease modeling to drug discovery. Curr. Opin. Drug Discov. Devel. 6, 218-223 (2003).
20. Amatruda, J. F., Shepard, J. L., Stern, H. M. & Zon, L. I. Zebrafish as a cancer model system. Cancer Cell 1, 229-231 (2002).
21. Amsterdam, A. et al. Identification of 315 genes essential for early zebrafish development. Proc. Natl Acad. Sci. USA 101, 12792-12797 (2004).
22. Sun, Z. et al. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development 131, 4085-4093 (2004).
23. Otto, E. A. et al. Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination, Nature Genet. 34, 413-420 (2003).
24. Poss, K. D., Keating, M. T. & Nechiporuk, A. Tales of regeneration in zebrafish. Dev. Dyn. 226, 202-210 (2003).
25. Gerull, B. et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nature Genet. 30, 201-204 (2002).
26. Xu, X. et al. Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nature Genet 30, 205-209 (2002).
27. Li, Q. Y. et al. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nature Genet. 15, 21-29 (1997).
28. Garrity, D. M., Childs, S. & Fishman, M. C. The heartstrings mutation in zebrafish causes heart/fin Tbx5 deficiency syndrome. Development 129, 4635-4645 (2002).
29. Curran, M. E. et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80, 795-803 (1995).
30. Langheinrich, U., Vacun, G. & Wagner, T. Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia. Toxicol. Appl. Pharmacol. 193, 370-382 (2003).
31. Donovan, A. et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781 (2000).
32. Njajou, O. T. et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nature Genet. 28, 213-214 (2001).
33. Davidson, A. J. et al. cdx4 mutants fail to specify blood progenitors and can be rescued by multiple hox genes. Nature 425, 300-306 (2003).
34. Kalev-Zylinska, M. L. et al. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Development 129, 2015-2030 (2002).
35. Langenau, D. M. et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 299, 887-890 (2003).
36. Li, L. & Dowling, J. E. A dominant form of inherited retinal degeneration caused by a non-photoreceptor cell-specific, mutation. Proc. Natl Acad. Sci. USA 94, 11645-11650 (1997).
37. Peitsaro, N., Kaslin, J., Anichtchik, O. V. & Panula, P. Modulation of the histaminergic system and behaviour by α-fluoromethylhistidine in zebrafish. J. Neurochem. 86, 432-441 (2003).
38. Nicolson, T. et al. Genetic analysis of vertebrate sensory hair cell mechanosensation: the zebrafish circler mutants. Neuron 20, 271-283 (1998).
39. Malicki, J. et al. Mutations affecting development of the zebrafish ear. Development 123, 275-283 (1996).
40. Neuhauss, S. C. et al. Genetic disorders of vision revealed by a behavioral screen of 400 essential loci in zebrafish. J. Neurosci. 19, 8603-8615 (1999).
41. Darland, T. & Dowling, J. E. Behavioral screening for cocaine sensitivity in mutagenized zebrafish. Proc. Natl Acad. Sci. USA 98, 11691-11696 (2001).
42. /- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc. Natl Acad. Sci. USA 101, 6553-6558 (2004).
43. Kenwrick, S., Amaya, E. & Papalopulu, N. Pilot morpholino screen in Xenopus tropicalis identifies a novel gene involved in head development. Dev Dyn. 229, 289-299 (2004).
44. Yamada, L. et al. Morpholino-based gene knockdown screen of novel genes with developmental function in Ciona intestinalis. Development 130, 6485-6495 (2003).
45. Tolbert, J. A. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nature Rev. Drug Discov. 2, 517-526 (2003).
46. Clader, J. W. The discovery of ezetimibe: a view from outside the receptor. J. Med. Chem. 47, 1-9 (2004).
47. Altmann, S. W. et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303, 1201-1204 (2004).
48. Robson, J. M. & Keele, C. A. Recent Advances in Pharmacology (J. & A. Churchill, London 1956).
49. Peterson, R. T. et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nature Biotechnol. 22, 595-599 (2004).
50. Stern, H. M. & Zon, L. I. Cancer genetics and drug discovery in the zebrafish. Nature Rev. Cancer 3, 533-539 (2003).
51. Zhong, T. P., Rosenberg, M., Mohideen, M. A., Weinstein, B. & Fishman, M. C. gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 287, 1820-1824 (2000).
52. Zhong, T. P., Childs, S., Leu, J. P. & Fishman, M. C. Gridlock signalling pathway fashions the first embryonic artery. Nature 414, 216-220 (2001).
53. Langenau, D. M. et al. In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish. Proc. Natl Acad. Sci. USA 101, 7369-7374 (2004).
54. Traver, D. et al. Effects of lethal irradiation in zebrafish and rescue by hematopoietic call transplantation. Blood 104, 1298-1305 (2004).
55. Poss, K. D., Wilson, L. G. & Keating, M. T. Heart regeneration in zebrafish. Science 298, 2188-2190 (2002).
56. Guo, S. Linking genes to brain, behavior and neurological diseases: what can we learn from zebrafish? Genes Brain Behav. 3 63-74 (2004).
57. Ulrich, R. & Friend, S. H. Toxicogenomics and drug discovery: will new technologies help us produce better drugs? Nature Rev. Drug Discov. 1, 84-88 (2002).
58. Llorens, O., Perez, J. J. & Villar, H. O. Toward the design of chemical libraries for mass screening biased against mutagenic compounds. J. Med. Chem. 44, 2793-2804 (2001).
59. Pritchard, J. F. et al. Making better drugs: decision gates in non-clinical drug development. Nature Rev. Drug Discov. 2, 542-553 (2003).
60. Spitsbergen, J. M. & Kent, M. L. The state of the art of the zebrafish model for toxicology and toxicologic pathology research - advantages and current limitations. Toxicol. Pathol. 31 Suppl, 62-87 (2003).
61. Parng, C., Seng, W. L., Semino, C. & McGrath, P. Zebrafish: a preclinical model for drug screening. Assay Drug Dev. Technol. 1 41-48 (2002).
62. Brion, F. et al. Impacts of 17β-estradiol, including environmentally relevant concentrations, on reproduction after exposure during embryo-larval-, juvenile- and adult-life stages in zebrafish (Danio rerio). Aquat. Toxicol. 68, 193-217 (2004).
63. Levin, E. D., Chrysanthis, E., Yacisin, K. & Linney E. Chlorpyrifos exposure of developing zebrafish: effects on survival and long-term effects on response latency and spatial discrimination. Neurotoxicol. Teratol. 25, 51-57 (2003).
64. Schilling, T. F. & Knight, R. D. Origins of anteroposterior patterning and Hox gene regulation during chordate evolution. Philos. Trans. R Soc. Lond. B Biol. Sci. 356, 1599-1613 (2001).
65. Spitsbergen, J. M. et al. Neoplasia in zebrafish (Danio rerio) treated with 7,12-dimethylbenz[a]anthracene by two exposure routes at different developmental stages. Toxicol. Pathol. 28, 705-715 (2000).
66. Murakami, S. L. et al. Developmental differences in susceptibility to neomycin-induced hair cell death in the lateral line neuromasts of zebrafish (Danio rerio). Hear. Res. 186, 47-56 (2003).
67. Amanuma, K., Takeda, H., Amanuma, H. & Aoki, Y. Transgenic zebrafish for detecting mutations caused by compounds in aquatic environments. Nature Biotechnol. 18, 62-65 (2000).
68. Milan, D. J., Peterson, T. A., Ruskin, J. N., Peterson, R. T. & MacRae, C. A. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 107, 1355-1358 (2003 ).
69. Langheinrich, U. Zebrafish: a new model on the pharmaceutical catwalk. Bioessays 25, 904-912 (2003).
70. Greaves, P., Williams, A. & Eve, M. First dose of potential new medicines to humans: how animals help. Nature Rev. Drug Discov. 3, 226-236 (2004).
71. Christensen, C. M. The Innovator's Dilemma: When New Technologies Cause Great Firms to Fail (Harvard Business School Press, Boston, Massachusetts, 1997).
72. Solnica-Krezel, L., Schier, A. F. & Driever, W. Efficient recovery of ENU-induced mutations from the zebrafish germline. Genetics 136, 1401-1420 (1994).
73. Amsterdam, A. Insertional mutagenesis in zebrafish. Dev. Dyn. 228, 523-534 (2003).
74. Kwok, C. et al. Characterization of whole genome radiation hybrid mapping resources for non-mammalian vertebrates. Nucleic Acids Res. 26, 3562-3566 (1998).
75. Hukriede, N. A. et al. Radiation hybrid mapping of the zebrafish genome. Proc. Natl Acad. Sci. USA 96, 9745-9750 (1999).
76. Geisler, R. et al. A radiation hybrid map of the zebrafish genome. Nature Genet. 23, 86-89 (1999).
77. Affymatrix GeneChip Array Products [online],
78. Zebrafish Genome Resources [online],
79. Zebrafish International Resource Center [online],
80. Tübingen Zebrafish Stockcenter [online],
81. The Sanger Institute Danio rerio Sequencing Project [online],
82. Trans-NIH Zebrafish Initiative [online],